Questions You May Already Have:
- Why am I feeling this way?
Exact causes of mental disorders are still unknown, however we can certainly say that some conditions are inherited and triggered by the environment. The distinction between “mental” illness and “physical” illness can be misleading. In fact, they are often intertwined. Today, we have made tremendous progress in our understanding and our ability to diagnose disorders and offer effective treatments -as effective as treatments for high blood pressure, diabetes, and cancer. It is essential to find a psychiatrist with a good treatment model.
- What is "good" treatment?
Good treatment takes a comprehensive approach. Psychiatric treatment involves a full mental and medical evaluation and an individualized treatment plan. This includes laboratory evaluations to determine if there is an underlying medical cause creating the troubling symptoms. Medication is often not the only treatment for an acute or chronic illness. A combination of psychotherapy (talk therapy), medication, or other modalities are often integrated into a well developed treatment plan.
- How is Dr. Mogali different from other psychiatrists?
Dr. Mogali completed her residency at the prestigious Emory University in Atlanta and then further advanced her training in Addiction Psychiatry at Columbia University College of Physicians and Surgeons in Manhattan. Dr. Mogali is a contributing author, having written a chapter in a major textbook named Research and Development of Opioid-Related Ligands. She is well published in top journals, pushing the field of forward and contributing to a better understanding of the disease processes she treats. She is a faculty member at the Columbia University/ New York State Psychiatric Institute. More than just accolades, Dr. Mogali
strives to help patients understand and live successfully with their illness.
To this end, she spends a great deal of energy teaching and coaching patients on
what they can do to resolve life problems that contribute to their distress.
These problems may include issues with school, work, family and community. Dr.
Mogali believes in taking a thorough approach to the patient’s needs. She will
take into account educational, medical, spiritual, and interpersonal needs, as
well as basic issues (such as proper housing and nutrition) during her evaluations. Sometimes people
misuse drugs and alcohol. Dr. Mogali is board certified in the treatment of drug
abuse and can help stabilize this behavior. Some doctors come from a different
way of thinking and education. Textbooks and methods change with
time, as do people. Experience with a fresh education and perspective makes Dr.
Mogali unique amongst other psychiatrists.
1. Jones JD, Sullivan MA, Vosburg SK, Manubay JM, Mogali S, Metz V, Comer SD. (2014).
Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in
buprenorphine-maintained heroin users. Addict Biol.
2. Comer SD, Mogali S, Saccone PA, Askalsky P, Martinez D,
Walker EA, Jones JD, Vosburg SK, Cooper ZD, Roux P, Sullivan MA, Manubay JM,
Rubin E, Pines A, Berkower EL, Haney M, Foltin RW. (2013). Effects of acute
oral naltrexone on the subjective and physiological effects of oral
d-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology.
3. Roux P, Sullivan MA, Cohen J, Fugon L, Jones JD, Vosburg
SK, Cooper ZD, ManubayJM, Mogali S, Comer SD. (2013). Buprenorphine/naloxone as
a promising therapeutic option for opioid abusing patients with chronic pain:
reduction of pain, opioid withdrawal symptoms, and abuse liability of oral
oxycodone. Pain. Aug;154(8):1442-8.
4. Gudin JA, Mogali S, Jones JD, Comer SD. (2013). Risks,
management, and monitoring of combination opioid, benzodiazepine, and/or
alcohol use. Postgrad Med. Jul;125(4):115-30.
5. Mogali S, Comer SD. (2013). Treatment of Pain and
Opioid Abuse. In Mei-Chuan Ko, Stephen M. Husbands, Research and Development of
Opioid-Related Ligands (pp 39-60). Oxford University Press.
6. Jones JD, Mogali S, Comer SD. (2012). Polydrug abuse: A
review of opioid and benzodiazepine combination use. Drug Alcohol Depend. Sep
1;125 (1-2): 8-18.
7. Mogali S, Darville K, Pratt LM. (2001) Ab initio
analysis of lithium dimethylaminoborohydride. J Org Chem. Apr 6; 66(7):2368-73.
8. Mogali S, Comer SD. Effects of Minocycline on Oxycodone-
Induced Responses. (Submitted).
9. Mogali S, Khan N, Drill E, Pavlicova M, Sullivan M,
Nunes E, Bisaga. Characteristics of Patients Completing Rapid Naltrexone
Induction-Detoxification as a Factor in Determining Client Suitability for
Opioid-Antagonist Treatment. (Submitted).
1. Mogali S, Comer SD. Effects of Minocycline on
Oxycodone-Induced Responses. College on Problems of Drug Dependence, San Diego,
CA, June 15-20, 2013.
2. Mogali S, Comer SD, Saccone PA, Roux P, Jones JD,
Cooper SZ, Vosburg SK, Sullivan MA, Rubin E, Manubay JM, Martinez DM, Walker EA, Haney M,
Foltin RW. Naltrexone reduces the subjective effects of oral d-amphetamine but
not smoked cocainein humans. College on Problems of Drug Dependence, Palm
Springs, CA, June 9-14, 2012.